Going to #ESMO24 & excited for expert talks + seeing colleagues in a beautiful European city? Or ru having FOMO? Either way, the next chance is on the horizon! 👀 at the St.Gallen Breast Ca Consensus Conf panelists! Hope u join me in Vienna!#SGBCC2025 sg-bcc.org/programme/pane…

Highly recommend advanced fellowship for physicians scientists wishing to improve their clinical acumen in breast cancer and deepen their research toolkit. Dana-Farber’s Breast Oncology Center

Facing a cancer diagnosis can be overwhelming. Dana-Farber's Breast Oncology Program has a dedicated patient navigator who helps lower barriers patients face when trying to access breast cancer care. Learn more: blog.dana-farber.org/insight/2024/0…

Great day for ⁦Dana-Farber⁩ and our med onc program ⁦Dana-Farber’s Breast Oncology Center⁩

🌞We had an amazing time at the BOC department picnic this past weekend @TrilliumBrewing Fenway🌞From giant Jenga and cornhole to face painting, balloon art and ice cream treats, there was fun for everyone. Special thanks to all who joined us for the fun day!

“Regardless of your situation, there are almost always safe and effective treatments for #BreastCancer care in pregnancy,” says Erica Mayer, MD, MPH (Erica Mayer) director in the Breast Oncology Program Dana-Farber. Here’s what you should know: ms.spr.ly/6181lvNPP

Join us on Oct 18th for the #BreastCancer in #YoungAdults Forum hosted by Dr. Ann Partridge (Ann Partridge MD, MPH) founder and director of Young and Strong. This event is designed to connect you with Dana-Farber experts and build community. Register today: youngandstrong.dana-farber.org/2024-forum

Hot off the press in Annals of Oncology: Is adjuvant ribociclib ready for prime time? Recommended read in preparation for the NATALEE 4y update at #ESMO24 annalsofoncology.org/article/S0923-…

How would you treat a 45-year-old with hormone receptor–positive, HER2-negative, locally advanced early-stage breast cancer? Hope Rugo and Sara Tolaney discuss critical decisions & evolving strategies. bit.ly/479Xoqx #CDK46Inhibitors Dana-Farber’s Breast Oncology Center UCSF Helen Diller Family Comprehensive Cancer Ctr

New paper from Brittany Bychkovsky, MD and colleagues on the incidence of endometrial cancer in #BRCA mutation carriers. Open access here⬇️ pubmed.ncbi.nlm.nih.gov/39173195/ Nadine Tung MD Amber Aeilts Beth Karlan Robert Fruscio Charis Eng, MD, PhD Olufunmilayo Olopade Fergus Couch Teresa Alonso Gordoa Steven Narod

How it started. How it’s going😉 Thank you incredible mentors Eli Van Allen and Kent Mouw, role models surgeon-scientists Dr. E Mittendorf Chris Barbieri, collaborators Michelle_Hirsch (Donovan) Jennifer Guerriero, PhD joaquim bellmunt, our BWH comp urology group, my wife Filipa Lynce, MD, FASCO, fam and friends

🔍 Top 10 Breast Cancer Abstracts at ESMO - Eur. Oncology 2024 📊 Paolo Tarantino highlights must-see abstracts, from phase 3 readouts to novel ADCs and targeted drugs Have a look at the top 10 picks: oncodaily.com/blog/136264 #Cancer #Health #Medicine #OncoDaily #Oncology

Why is #SGBCC2025 a must-attend for young doctors? Hear it directly from Harold Burstein, a member of our Scientific Committee 🌟 #YoungDoctors #MedicalEducation #BreastCancerCare #SGBCC2025 #NetworkingOpportunity #Win

Team science, where you can bring together diverse expertise of multiple people, is always going to be the best strategy to find novel strategies to curr cancer. Grateful for amazing colleagues. Thank you Rizwan Romee, Dan Michaud, PhD, Alex Gottlieb, Mubin Tarannum.

Register today for the 2024 DF/HCC Breast Cancer Program Research Retreat titled AI-Driven Cancer Solutions: From Basic Science to Standard of Care in #BreastCancer & Beyond. 🗓️Fri Sept 20th, 12:00-6:00pm 📍 Starr Center, MGH, 185 Cambridge St, Boston dfhcc.harvard.edu/events/breast-…

Dana-Farber’s Breast Oncology Center is leading a trial on the use of #ColdCaps in preventing #HairLoss with novel #BreastCancer therapies, including sacituzumab, eribulin, or trastuzumab deruxtecan. Contact us for info about the study or visit: dana-farber.org/clinical-trial… 🧊#ScalpCooling PI Elahe Salehi DNP

In this recording from the 2nd annual #DuctalCarcinomaInSitu Patient Forum, Brittany Bychkovsky, MD, MSc (Brittany Bychkovsky, MD), discuses #EndocrineTherapy for #DCIS. Watch here:⬇️⬇️⬇️ youtube.com/watch?v=J4CcGX…

New📰| Association between #TumorInfiltratingLymphocytes and survival in patients with #MetastaticBreastCancer receiving first-line chemotherapy: Analysis of CALGB 40502 from the Daniel Stover, MD, FASCO Erica Mayer Ann Partridge MD, MPH Sherene Loi, MD et al. 🔓Read it here: pubmed.ncbi.nlm.nih.gov/39169033/#full… #TILs

Proud to collaborate on this clinical trial at Dana-Farber with Elahe Salehi DNP #ChangingTheFaceOfCancer #ScalpCooling Dana-Farber’s Breast Oncology Center

Congratulation to Dr. Ting Bao (Ting Bao, MD), Co-Director of Dana-Farber Zakim Center Center for Integrative Therapies and Healthy Living, on her Society for Integrative Oncology 2024 Fellow Award!